Lifetime Cancer Risks in Individuals With Germline PTEN Mutations

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-11-2283
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Molecular and Phenotypic Abnormalities in Individuals With Germline Heterozygous PTEN Mutations and Autism

Molecular Psychiatry
PsychiatryMolecular NeuroscienceMental HealthMolecular BiologyCellular
2014English

No Evidence of Germline PTEN Mutations in Familial Prostate Cancer

Journal of Medical Genetics
Genetics
2000English

CDKN2A Germline Mutations in Individuals With Cutaneous Malignant Melanoma

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2007English

Second Malignant Neoplasms in Patients With Cowden Syndrome With Underlying Germline PTEN Mutations

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2014English

Germline PTEN Mutations Are Rare and Highly Penetrant

Hereditary Cancer in Clinical Practice
OncologyGenetics
2006English

Recurrent Germline DLST Mutations in Individuals With Multiple Pheochromocytomas and Paragangliomas

American Journal of Human Genetics
Genetics
2019English

Conformational Dynamics and Allosteric Regulation Landscapes of Germline PTEN Mutations Associated With Autism Compared to Those Associated With Cancer

American Journal of Human Genetics
Genetics
2019English

Germline Mutations in Cancer-Predisposition Genes in Patients With Biliary Tract Cancer

Oncotarget
Oncology
2019English

Prevalence of Germline Mutations in Cancer Predisposition Genes in Patients With Pancreatic Cancer

Gastroenterology
HepatologyGastroenterology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy